Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...

India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics , a U.S.-based immunotherapy and targeted oncology company, for $355 million.

Sun Pharmaceutical Industries announces acquisition of US-based Checkpoint Therapeutics for up to USD 355 million. The Indian ...

Sun Pharmaceutical Industries Ltd. closed 15.54% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Sun Pharma has acquired Checkpoint Therapeutics for $355 million, enhancing its onco-dermatology portfolio with the ...

While the brokerage remains positive on the growth outlook for Sun’s key specialty brands (Ilumya, Winlevi, and Cequa), it noted some delays in clinical trials for pipeline assets. However ...

Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.26% to 1,609.90 Indian rupees Friday, on what proved to be an all-around poor trading session for the stock market, with the BSE ...

Aadhar Housing Finance allotted 4,85,757 shares to employees. Sun Pharma faces a ₹1,60,22,86,699 penalty under CGST Act. Torrent also received a CGST penalty order. Stay tuned! Sun Pharma’s ...

Share prices of Sun Pharmaceutical Industries Ltd., Tata Steel Ltd., Bajaj Finserv Ltd., Bajaj Finance Ltd., and Kotak Mahindra Bank Ltd. emerged as the top gainers on Wednesday. Among the ...

India's Sun Pharmaceutical Industries said on Monday that it will acquire Checkpoint Therapeutics , a U.S.-based immunotherapy and targeted oncology company, in a deal valued at up to $355 million.

Sun Pharma Advanced Research Company Ltd share price was up by 8.37% from the previous closing price of ₹126.05. Who are peers of Sun Pharma Advanced Research Company Ltd? The peers of Sun ...